First experience using LMI1195 PET in patients with the suspicion of pheochromocytoma or paraganglioma

Conclusions: LMI1195, a novel F-18-labeled PET-tracer, is highly effective in detecting tumors of the adrenal medulla or the sympathetic trunk. High uptake in lesions and superb image quality promote its use as alternative to MIBG. Further potential applications (e.g. assessment of the sympathetic innervation of the heart) should be evaluated.

Source: Journal of Nuclear Medicine - May 23, 2018 Category: Nuclear Medicine Authors: Rischpler, C., Schlitter, A., Herz, M., Yousefi, B., Von Werder, A., Tauber, R., Maurer, T., Robinson, S., Orlandi, C., Nekolla, S., Schwaiger, M., Eiber, M. Tags: First-in-Human & amp; New Human Applications Source Type: research